PaxMedica, Inc.(PXMD)_个股概要_股票价格_最新资讯_行情走势_历史数据

PaxMedica, Inc.(PXMD)

0.7600+0.0558+7.92%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
PaxMedica, Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.paxmedica.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
PaxMedica, Inc.于2018年4月5日成立为特拉华州有限责任公司，并于2020年4月15日转换为特拉华州公司。该公司是一家早期临床阶段生物制药公司，专注于开发抗嘌呤能疗法（或APT），用于治疗神经发育障碍，包括自闭症谱系障碍（ASD）和脆性X综合征震颤性共济失调（FXTAS）。
- 04-23
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 04-16
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 04-11
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 03-22
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 03-13
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 03-11
  年度报告
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 02-13
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 01-30
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 01-13
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2023-12-21
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2023-12-01
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2023-11-30
  超过5%披露
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2023-11-30
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2023-11-23
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2023-11-17
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence